May 14, 2013 - American CryoStem Collaborates With RUAmerican CryoStem Corporation (OTCQB:CRYO), a lead...
April 1, 2013 - NJ.com Features Meadowlands AcceleratorNJ.com featured the Meadowlands Regional Accelerat...
February 23, 2011 - Aestus Therapeutics Initiates Phase 2 Clinical Trial
Aestus Therapeutics Initiates Phase 2 Clinical Trial for Novel Neuropathic Pain Treatment
Aestus Therapeutics, Inc. (Aestus), announced today that it has initiated screening of patients for a clinical trial to evaluate the efficacy of its novel pain therapeutic, ATx08-001. This placebo-controlled, two-dose level study will test the efficacy of ATx08-001 in reducing the pain following an outbreak of shingles.
Aestus Therapeutics is located at the Commercialization Center for Innovative Technologies, a member of the New Jersey Business Incubation Network.
To view a full press release, click on the PDF link below.
|Last Updated on Friday, 25 February 2011 14:14|